3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Leukemia, Myeloid, Acute
78
Precursor Cell Lymphoblastic Leukemia-Lymphoma
71
Leukemia, Lymphocytic, Chronic, B-Cell
70
Myelodysplastic Syndromes
64
Hodgkin Disease
63
Multiple Myeloma
59
Lymphoma, Non-Hodgkin
58
Leukemia
53
Lymphoma, Follicular
44
Lymphoma, Mantle-Cell
43
Lymphoma, Large B-Cell, Diffuse
41
Lymphoma
41
Myeloproliferative Disorders
39
Lymphoma, B-Cell, Marginal Zone
37
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
37
Leukemia, Myeloid, Chronic-Phase
35
Congenital Abnormalities
35
Burkitt Lymphoma
33
Lymphoma, Large-Cell, Immunoblastic
30
Leukemia, Myelomonocytic, Chronic
29
Leukemia, Myeloid, Accelerated Phase
27
Waldenstrom Macroglobulinemia
25
Anemia, Refractory, with Excess of Blasts
25
Hematologic Neoplasms
23
Graft vs Host Disease
21
Recurrence
20
Dendritic Cell Sarcoma, Interdigitating
20
Primary Myelofibrosis
19
Lymphoma, T-Cell, Cutaneous
19
Blast Crisis
19
Interventions
Oncolytic Virotherapy
2
Cancer Vaccines
2
Adjuvants, Immunologic
2
pembrolizumab
1
pamiparib
1
interferon gamma-1b
1
glutathione pegylated liposomal doxorubicin
1
Trastuzumab
1
Telemedicine
1
Radiation
1
Plasma Exchange
1
Mycophenolic Acid
1
Interferon-gamma
1
Immunotherapy
1
COVID-19 Vaccines
1
Azathioprine
1
Antibodies, Monoclonal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Nervous System Diseases
×
Mycophenolic Acid
×
Clear all
NCT03490539
2021-02-03
PROMISE-MG
Duke University
Completed
167 enrolled